Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newborn screening for lysosomal storage disorders.

Peter J Meikle1, Dallas J Grasby, Caroline J Dean

  • 1Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children Youth and Women's Health Service, North Adelaide, South Australia 5006, Australia. peter.meikle@adelaide.edu.au

Molecular Genetics and Metabolism
|April 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and Environmental Influences on Dental Arch Shape During Development: A Longitudinal Twin Study.

Orthodontics & craniofacial research·2026
Same author

Cerebrospinal fluid heparan sulfate as a biomarker for neuronopathic mucopolysaccharidoses: Rationale and regulatory challenges.

Molecular genetics and metabolism·2026
Same author

Two different products from the reaction between 2-formylphenylboronic acid and benzhydrazide: benzoyl hydrazone versus dimer.

Acta crystallographica. Section C, Structural chemistry·2026
Same author

Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates.

International journal of molecular sciences·2025
Same author

Sphingolipids in Gaucher disease: a systematic review.

Orphanet journal of rare diseases·2025
Same author

Implications of Altered Endosomal-Lysosomal Biogenesis in Melanoma Pathogenesis.

International journal of molecular sciences·2025

Newborn screening for lysosomal storage disorders (LSD) is now achievable using a multiplexed immune-quantification assay. This method identifies affected infants early, enabling timely intervention and improved patient outcomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Lysosomal storage disorders (LSDs) are chronic, progressive genetic diseases with significant patient and family impact.
  • Early childhood symptoms develop, often after irreversible pathology, highlighting the need for early detection.
  • Current therapeutic options focus on improving quality of life, underscoring the importance of timely diagnosis.

Purpose of the Study:

  • To develop and evaluate a multiplexed immune-quantification assay for identifying individuals with LSDs.
  • To assess the assay's efficacy in a retrospective study using blood spots from newborns and diagnosed patients.
  • To determine the feasibility of incorporating this assay into newborn screening programs.

Main Methods:

  • Development of a multiplexed immune-quantification assay measuring 11 different lysosomal proteins.

Related Experiment Videos

  • Retrospective analysis of blood spots from newborns diagnosed with LSDs, post-diagnosis patients, and control groups.
  • Comparison of lysosomal protein levels against established control ranges.

    • Main Results:

    • The assay successfully identified patients with various LSDs, including MPS I, MPS II, MPS IIIA, MPS VI, metachromatic leukodystrophy, Niemann-Pick disease A/B, and multiple sulfatase deficiency via reduced enzyme levels.
    • Mucolipidosis type II/III patients were identified by elevated lysosomal enzyme levels.
    • Fabry, Pompe, and Gaucher disease patients were often identified through single protein differences or combined marker profiles.

    Conclusions:

    • Multiplexed immune-quantification of lysosomal proteins is a viable method for newborn screening of multiple LSDs.
    • This assay shows potential for early identification of LSDs, facilitating improved patient management and family counseling.
    • Further validation could lead to integration into existing newborn screening laboratories, significantly impacting patient care.